China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.0310
-0.0190 (-38.00%)
At close: Jan 30, 2026, 4:00 PM EST
0.0306
-0.0004 (-1.29%)
After-hours: Jan 30, 2026, 7:59 PM EST

China SXT Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
434131129
Market Cap Growth
218.08%3514.19%-67.93%-73.95%-60.15%83.78%
Enterprise Value
-1626-721419
Last Close Price
0.032.4913.4456.721120.007360.00
PS Ratio
1.1919.720.491.504.375.97
PB Ratio
0.182.220.070.200.691.79
P/TBV Ratio
0.212.230.070.200.691.79
P/FCF Ratio
----55.27-
P/OCF Ratio
----42.40-
EV/Sales Ratio
-14.76-0.795.373.93
EV/FCF Ratio
----67.88-
Debt / Equity Ratio
0.060.060.270.610.650.76
Debt / FCF Ratio
----52.20-
Asset Turnover
0.050.080.070.060.080.17
Inventory Turnover
0.701.421.981.881.101.60
Quick Ratio
4.043.331.511.311.141.00
Current Ratio
4.373.541.601.351.311.25
Return on Equity (ROE)
-50.30%-22.50%-21.65%-38.15%-35.42%-21.67%
Return on Assets (ROA)
-18.27%-7.48%-4.96%-10.42%-9.53%-4.88%
Return on Invested Capital (ROIC)
-6457.21%-143.27%-35.35%-58.67%-39.22%-18.57%
Return on Capital Employed (ROCE)
-41.10%-17.10%-14.70%-34.90%-31.60%-13.80%
Earnings Yield
-204.33%-9.62%-326.13%-200.33%-50.43%-9.63%
FCF Yield
-63.18%-6.84%-203.68%-5.11%1.81%-4.94%
Buyback Yield / Dilution
-21127.69%-1212.67%-224.91%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q